期刊文献+

SIAH2与Bcl-2在乳腺癌中的表达和相关性研究 被引量:4

Expression and Correlation of SIAH2 and Bcl-2 in Breast Cancer
在线阅读 下载PDF
导出
摘要 目的:分析正常乳腺组织和浸润性导管癌中SIAH2和Bcl-2的表达及临床意义,探讨其在乳腺癌发生发展中的作用及相关性。方法:采用免疫组织化学S-P法检测SIAH2和Bcl-2蛋白的表达,并分析二者的相关性及与临床病理因素的关系;采用Western Blot法检测SIAH2和Bcl-2蛋白的表达。结果:SIAH2与Bcl-2蛋白在乳腺癌癌变过程中的阳性表达率逐渐升高,并且二者表达与乳腺癌组织学分级、ER、PR相关。免疫组化结果表明SIAH2与Bcl-2蛋白在乳腺正常组织和浸润性导管癌中的阳性表达率分别为8.7%和17.4%,75%和72.5%。统计学结果显示在80例乳腺癌组织中,SIAH2与Bcl-2蛋白表达呈正相关(P<0.001,r_s=0.485)。Western blot结果表明SIAH2与Bcl-2蛋白在乳腺癌组织中表达高于癌旁乳腺组织,在乳腺癌细胞系MDA-MB-435S和MCF-7中表达高于乳腺正常上皮细胞系MCF-10A。结论:SIAH2与Bcl-2在乳腺癌发生发展中均存在异常,并且两者可能存在某种协调关系。 Objective: To investigate the expression and significance of both seven in absentia homology 2 ( SIAH2 ) and B-cell lymphoma 2 ( Bcl-2 ) in normal mammary glands and invasive ductal carcinoma ( IDC ) and to discuss the role and correlation between them during breast carcinogenesis. Methods: SIAH2 and Bcl-2 expression were determined using immunohistochemical SP method, and the relationship between the SIAH2 and Bcl-2 protein expression and the clinical pathologic features were analyzed. Western blot analysis was conducted to determine the SIAH2 and Bcl-2 expression. Results: SIAH2 and Bcl-2 expression significantly increased during breast carcinogenesis and were correlated with histologic grade, as well as estrogen and progesterone receptor expression. The immunohistochemistry results showed that there was an increasing tendency in positive expression rate of SIAH2 and Bcl-2 in normal breast tissues ( 8.7% and 17.4%, respectively ) to IDC (7 5% and 72.5%, respectively ). Spearman's correlation revealed that SIAH2 expression was significantly correlated with Bcl-2 expression in the 80 breast cancer specimens ( P 〈 0.001, rs = 0.485 ). Western blot analysis showed that SIAH2 and Bcl-2 protein expression were significantly higher in breast tumor tissues compared with those in paraneoplastic tissues, which was the same compared with the protein expression among the human breast cancer MDA-MB-435S and MCF-7 cell lines, and the normal breast epithelial MCF-10A cell line. Conclusion: Our results indicated that both SIAH2 and Bcl-2 are involved in breast cancer and may imply coordination in breast tumorigenesis.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2011年第15期898-901,共4页 Chinese Journal of Clinical Oncology
关键词 SIAH2 BCL-2 乳腺癌 Seven in absentia homology 2 Bcl-2 Breast cancer
作者简介 通信作者:李栢林Libailin99@yahoo.com.cn
  • 相关文献

参考文献10

  • 1Wen YY, Yang ZO~ Song M, et al. The expression of SIAH1 is down-regulated and associated with Bim and apoptosis in human breast cancer tissues and cells[J].Mol Carcinog, 2010, 49(5): 440-449.
  • 2Qi J, Nakayama K, Gaitonde S, et al. The ubiquitin ligase Siah2 regulates tumorigenesis and metastasis by HIF-dependent and-independent pathways[l]. Proc Natl Acad Sci U S A, 2008, 105(43): 16713-16718.
  • 3Schmidt RL, Park CH, Ahmed AU, et al. Inhibition of RAS-mediated transformation and tumorigenesis by targeting the downstream E3 ubiquitin ligase seven in absentia homologue[J]. Cancer Res, 2007, 67(24): 11798-11810.
  • 4Wang CX, SongJH, Song DK, et al. Cyclin--dependent kinase-5 prevents neuronal apoptosis through ERK-mediated upregulation of Bcl-2 [J]. Cell Death Differ, 2006, 13(7): 1203-1212.
  • 5Subramanian M, Shaha C. Up-regulation of Bcl-2 through ERK phosphorylafion is associated with human macrophage survival in an estrogen microenvironment[J].J Immunol, 2007, 179(4): 2330-2338.
  • 6Wen YY, Yang ZQ,Song M, et al. SIAH1 induced apoptosis by activation of theJNK pathway and inhibited invasion by inactivation of the ERK pathway in breast cancer cells[J]. Cancer Sci, 2010, 101 (1) : 73-79.
  • 7Khurana A, Nakayama K, Williams S, et al. Regulation of the ring finger E3 ligase Siah2 by p38 MAPK[J]. J Biol Chem, 2006, 281 (46): 35316-35326.
  • 8Ahmed AU, Schmidt RL, Park CH, et al. Effect of disrupting seven-in-absentia homolog 2 function on lung cancer cell growth[J]. J Natl Cancer Inst, 2008, 100(22): 1606-1629.
  • 9Jansen MP, Ruigrok-Ritsder K, Dorssers LC, et al. Dowrtregulation of SIAH2, an ubiquitin E3 ligase, is associated with resistance to endocrine therapy in breast cancer[J]. Breast Cancer Res Treat, 2009, 116(2): 263-271.
  • 10Nathan B, Gusterson B, Jadayel D, et al. Expression of BCL-2 in primary breast cancer and its correlation with tttmour phenotype[J]. Ann Oncol, 1994, 5(5): 409-414.

同被引文献39

  • 1吴珏堃,唐勇,邱万寿.SIAH2在乳腺癌及癌旁组织中的差异表达及其临床意义[J].岭南现代临床外科,2012,12(6):403-406. 被引量:4
  • 2Tavassoli FA.乳腺及女性生殖器官肿瘤病理学和遗传学[M].程虹等译.北京:人民卫生出版社,2006.312.
  • 3Yenidunya S, Bayrak R,Haltas H. Predictive value of pathological and immunohistochemical parameters for axillary lymph node me- tastasis in breast carcinoma [ J ]. Diagn Pathol,2011,13 (6) :18 -18.
  • 4Perou CM,Srlie T,Eisen MB,et al.Molecular portraits of human breast tumours[J].Nature,2000,406(6797):747-752.
  • 5Sorlie T,Tibshirani R,Parker J,et al.Repeated observation of breast tumor subtypes in independent gene expression data sets[J].Proc Natl Acad Sci U S A,2003,100(14):8418-8423.
  • 6Scawn R,Shousha S.Morphologic spectrum of estrogen receptor-negative breast carcinoma[J].Arch Pathol Lab Med,2002,126(3):325-330.
  • 7Pracella D,Bonin S,Barbazza R,et al.Are breast cancer molecular classes predictive of survival in patients with long follow-up[J].Dis Markers,2013,35(6):595-605.
  • 8Pavlenko IA,Povilaǐtite PE,Gorelik MZ,et al.Bcl-2 as a prognostic factor in different molecular genetic subtypes of breast cancer[J].Arkh Patol,2012,74(5):36-40.
  • 9Shi YY,Nacamuli RP,Salim A,et al.The osteogenic potential of adipose-derived Mesenchymal cells is maintained with aging[J].Plast Reconstr Surg,2005,116(6):1686-1696.
  • 10Rakha EA,El2Sayed ME,Green AR,et al.Prognostic markers in triple-negative breast cancer[J].Cancer,2007,109(1):25-32.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部